Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Novo Nordisk is one of the world’s most successful global pharmaceutical companies having a reputed history for bringing innovative therapeutic products to patients worldwide and having a great long-term growth potential.
Post : Pharma Patent Attorney